The radial approach for PCI reduces mortality

Original title: Radial Versus Femoral Access for Primary Percutaneous Interventions in ST-Segment Elevation Myocardial Infarction Patients. A Meta-Analysis of Randomized Controlled Trials. Reference: Wassef Karrowni et al. J Am Coll Cardiol Intv 2013;6:814–23.

Bleeding is the most frequent in-hospital complication of PCI, and it is clearly associated with adverse events that include death.   STEMI patients require emergency revascularization as well as an aggressive antiplatelet and antithrombotic therapy that will make them more susceptible to bleeding. Since bleeding events are strongly associated to access site, the radial approach is an attractive strategy where bleeding risks should often be counterbalanced with a longer procedure time, which is a significant factor in the context of PCI.

This meta-analysis included 12 randomized studies that evaluated the outcomes of radial vs. femoral access for PCI in 5055 patients (2492 radial access vs. 2562 femoral access patients). The use of IIbIIIa glycoprotein inhibitors was common to all studies and with similar rates in both branches. Crossover from one access site to the other was more frequent for the radial approach (4.6%) compared to the femoral (1.1%).

A significant reduction of mortality risk was observed in the radial group compared to the femoral group (2.7% vs. 4.7%; OR 0.55, 95% IC 0.4 to 0.76; p<0.001) associated with a similar reduction in major bleeding (1.4% vs. 2.9%; OR 0.51, 95% IC 0.31 to 0.85; p<0.05). Relative risk of access site bleeding also decreased significantly (radial 2.1% vs. femoral 5.6%; OR 0.35, 95% IC 0.25 a 0.50; p<0.001). Stroke and MI risk were similar between both approaches.

Conclusion:

This meta-analysis outcomes show a reduction in mortality and bleeding favorable to the radial approach compared to the femoral approach in STEMI patients receiving PCI. 

Editorial Comment

All studies analyzed did not include patients in cardiogenic shock with the exception for the RIFLE-STEACS , which did not show difficulties in using the radial approach. PCI could be performed by radial approach in unstable patients, and the femoral approach could be reserved for counter pulsation balloon procedures, to mention an example. 

Procedure time resulted 1.5 minutes longer than the average in the radial group (95% IC 0.33 to 2.70; p=0.01). Although this point was frequently objected by femoral access advocates, it seems unimportant even in the context of PCI.

SOLACI.ORG

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...